Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

✍ Scribed by Gotto, Antonio M.; Cannon, Christopher P.; Li, Xiujiang Susie; Vaidya, Sanskruti; Kher, Uma; Brinton, Eliot A.; Davidson, Michael; Moon, Jennifer E.; Shah, Sukrut; Dansky, Hayes M.; Mitchel, Yale; Barter, Philip

• Book ID: 122104391
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 753 KB
• Volume: 113
• Category: Article
• ISSN: 0002-9149
• DOI: 10.1016/j.amjcard.2013.08.041